Abstract
A view that l-glutamic acid (Glu) plays a role as an excitatory amino acid neurotransmitter through mechanisms relevant to activities of a variety of signaling machineries essential for the neurocrine at synapses in the brain is prevailing. Although expression of functional receptors is an absolute requirement for the glutamatergic signal input in the brain, recent molecular biological and pharmacological studies including ours give rise to a novel concept for Glu as an extracellular signal mediator in the autocrine and/or paracrine system in several non-neuronal tissues outside the brain. We have demonstrated functional expression of a variety of glutamatergic signaling machineries by bone-forming osteoblasts and mechano-sensing osteocytes in bone, in addition to chondrocytes in cartilage, which are all derived from primitive mesenchymal stem cells in bone marrows. We could also detect functional expression of the cystine/Glu antiporter comprised of both xCT and 4F2hc subunits, rather than any other glutamatergic signaling machineries, by bone-resorbing osteoclasts believed to originate in hematopoietic stem cells. On the basis of these findings, we would propose a universal role of Glu as an extracellular signal mediator in the neurocrine, autocrine and paracrine systems in our body. Clinical aspect is also discussed on dietary Glu intake with a focus on possible benefits for the prophylaxis and/or treatment of osteoporosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AMPA:
-
dl-α-amino-3-hydroxy-5-methylisoxasole-4-propionate
- EAAC1:
-
Excitatory amino acid carrier 1
- EAAT:
-
Excitatory amino acid transporter
- GLAST:
-
Glutamate aspartate transporter
- GLT-1:
-
Glutamate transporter-1
- Glu:
-
Glutamate
- GluR:
-
Glutamate receptor
- GSH:
-
Reduced glutathione
- iGluR:
-
Ionotropic glutamate receptor
- KA:
-
Kainate
- M-CSF:
-
Macrophage-colony stimulating factor
- mGluR:
-
Metabotropic glutamate receptor
- MK-801:
-
Dizocilpine
- MNCs:
-
Multinucleated cells
- MSCs:
-
Mesenchymal stem cells
- NMDA:
-
N-methyl-d-aspartate
- NMDAR:
-
N-methyl-d-aspartate receptor
- RA:
-
Rheumatoid arthritis
- RANK:
-
Receptor activator of NF-κB
- RANKL:
-
Receptor activator of NF-κB ligand
- Runx2:
-
Runt-related transcription factor-2
- TRAP:
-
Tartrate resistant acid phosphatase
- VGLUT:
-
Vesicular glutamate transporter
References
Yoneda Y, Ogita K. Localization of [3H]glutamate binding sites in rat adrenal medulla. Brain Res. 1986a;383:387–91.
Yoneda Y, Ogita K. [3H]Glutamate binding sites in the rat pituitary. Neurosci Res. 1986b;3:430–5.
Govitrapong P, Ebadi M, Murrin LC. Identification of a Cl−/Ca2+-dependent glutamate (quisqualate) binding site in bovine pineal organ. J Pineal Res. 1986;3:223–34.
Luzzi S, Zilletti L, Franchi-Micheli AM, Moroni F. Agonists, antagonists, and modulators of excitatory amino acid receptors in the guinea-pig myenteric plexus. Br J Pharmacol. 1988;95:1271–7.
Moroni F, Luzzi S, Franchi-Micheli S, Zilletti L. The presence of N-methyl-D-aspartate-type receptors for glutamic acid in the guinea-pig myenteric plexus. Neurosci Lett. 1986;68:57–62.
Shannon HE, Sawyer BD. Glutamate receptors of N-methyl-D-aspartate subtype in the myenteric plexus of guinea-pig ileum. J Pharmacol Exp Ther. 1989;251:518–23.
Aas P, Tanso R, Fonnum F. Stimulation of peripheral cholinergic nerves by glutamate indicates a new peripheral glutamate receptor. Eur J Pharmacol. 1989;164:93–102.
Hinoi E, Takarada T, Ueshima T, Tsuchihashi Y, Yoneda Y. Glutamate signaling in peripheral tissues. Eur J Biochem. 2004;271:1–13.
Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford T, Willing A, Freeman TB, Saporta S, Janssen W, Patel N, Cooper DR, Sanberg PR. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol. 2000;164:247–56.
Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res. 2000;61:364–70.
Chenu C, Serre CM, Raynal C, Burt-Pichat B, Delmas PD. Glutamate receptors are expressed by bone cells and are involved in bone resorption. Bone. 1998;22:295–9.
Mentaverri R, Kamel S, Wattel A, Prouillet C, Sevenet N, Petit JP, Tordjmann T, Brazier M. Regulation of bone resorption and osteoclast survival by nitric oxide: possible involvement of NMDA-receptor. J Cell Biochem. 2003;88:1145–56.
Peet NM, Grabowski PS, Laketic-Ljubojevic I, Skerry TM. The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation. FASEB J. 1999;13:2179–85.
Laketic-Ljubojevic I, Suva LJ, Maathuis FJ, Sanders D, Skerry TM. Functional characterization of N-methyl-D-aspartic acid-gated channels in bone cells. Bone. 1999;25:631–7.
Hinoi E, Fujimori S, Yoneda Y. Modulation of cellular differentiation by N-methyl-D-aspartate receptors in osteoblasts. FASEB J. 2003;17:1532–4.
Hinoi E, Fujimori S, Takemori A, Kurabayashi H, Nakamura Y, Yoneda Y. Demonstration of expression of mRNA for particular AMPA and kainate receptor subunits in immature and mature cultured rat calvarial osteoblasts. Brain Res. 2002a;943:112–6.
Hinoi E, Fujimori S, Takarada T, Taniura H, Yoneda Y. Facilitation of glutamate release by ionotropic glutamate receptors in osteoblasts. Biochem Biophys Res Commun. 2002b;297:452–8.
Gu Y, Publicover SJ. Expression of functional metabotropic glutamate receptors in primary cultured rat osteoblasts. Cross-talk with n-methyl-d-aspartate receptors. J Biol Chem. 2000;275:34252–9.
Hinoi E, Fujimori S, Nakamura Y, Yoneda Y. Group III metabotropic glutamate receptors in rat cultured calvarial osteoblasts. Biochem Biophys Res Commun. 2001;281:341–6.
Gray C, Marie H, Arora M, Tanaka K, Boyde A, Jones S, Attwell D. Glutamate does not play a major role in controlling bone growth. J Bone Miner Res. 2001;16:742–9.
Mason DJ, Suva LJ, Genever PG, Patton AJ, Steuckle S, Hillam RA, Skerry TM. Mechanically regulated expression of a neural glutamate transporter in bone: a role for excitatory amino acids as osteotropic agents? Bone. 1997;20:199–205.
Huggett J, Vaughan-Thomas A, Mason D. The open reading frame of the Na(+)-dependent glutamate transporter GLAST-1 is expressed in bone and a splice variant of this molecule is expressed in bone and brain. FEBS Lett. 2000;485:13–8.
Aarden EM, Burger EH, Nijweide PJ. Function of osteocytes in bone. J Cell Biochem. 1994;55:287–99.
Fujita H, Hinoi E, Nakatani E, Yamamoto T, Takarada T, Yoneda Y. Possible modulation of process extension by N-methyl-D-aspartate receptor expressed in osteocytic MLO-Y4 cells. J Pharmacol Sci. 2012;119:112–6.
Serre CM, Farlay D, Delmas PD, Chenu C. Evidence for a dense and intimate innervation of the bone tissue, including glutamate-containing fibers. Bone. 1999;25:623–9.
Morimoto R, Uehara S, Yatsushiro S, Juge N, Hua Z, Senoh S, Echigo N, Hayashi M, Mizoguchi T, Ninomiya T, Udagawa N, Omote H, Yamamoto A, Edwards RH, Moriyama Y. Secretion of L-glutamate from osteoclasts through transcytosis. EMBO J. 2006;25:4175–86.
Hinoi E, Takarada T, Uno K, Inoue M, Murafuji Y, Yoneda Y. Glutamate suppresses osteoclastogenesis through the cystine/glutamate antiporter. Am J Pathol. 2007;170:1277–90.
Wang L, Hinoi E, Takemori A, Takarada T, Yoneda Y. Abolition of chondral mineralization by group III metabotropic glutamate receptors expressed in rodent cartilage. Br J Pharmacol. 2005a;146:732–43.
Wang L, Hinoi E, Takemori A, Yoneda Y. Release of endogenous glutamate by AMPA receptors expressed in cultured rat costal chondrocytes. Biol Pharm Bull. 2005b;28:990–3.
Hinoi E, Wang L, Takemori A, Yoneda Y. Functional expression of particular isoforms of excitatory amino acid transporters by rodent cartilage. Biochem Pharmacol. 2005a;70:70–81.
Wang L, Hinoi E, Takemori A, Nakamichi N, Yoneda Y. Glutamate inhibits chondral mineralization through apoptotic cell death mediated by retrograde operation of the cystine/glutamate antiporter. J Biol Chem. 2006;281:24553–65.
Hinoi E, Ohashi R, Miyata S, Kato Y, Iemata M, Hojo H, Takarada T, Yoneda Y. Excitatory amino acid transporters expressed by synovial fibroblasts in rats with collagen-induced arthritis. Biochem Pharmacol. 2005b;70:1744–55.
Hinoi E, Yoneda Y. Possible involvement of glutamatergic signaling machineries in pathophysiology of rheumatoid arthritis. J Pharmacol Sci. 2011;116:248–56.
McNearney T, Speegle D, Lawand N, Lisse J, Westlund KN. Excitatory amino acid profiles of synovial fluid from patients with arthritis. J Rheumatol. 2000;27:739–45.
Lawand NB, McNearney T, Westlund KN. Amino acid release into the knee joint: key role in nociception and inflammation. Pain. 2000;86:69–74.
McNearney T, Baethge BA, Cao S, Alam R, Lisse JR, Westlund KN. Excitatory amino acids, TNF-alpha, and chemokine levels in synovial fluids of patients with active arthropathies. Clin Exp Immunol. 2004;137:621–7.
Riedijk MA, de Gast-Bakker DH, Wattimena JL, Van Goudoever JB. Splanchnic oxidation is the major metabolic fate of dietary glutamate in enterally fed preterm infants. Pediatr Res. 2007;62:468–73.
Acknowledgement
The author is highly indebted to all colleagues listed in the references cited in this chapter for their excellent and enthusiastic efforts to support experimental studies for a period from 1999 to 2015 in Laboratory of Molecular Pharmacology, Kanazawa University Graduate School.
Conflict of interest:
The author has no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Yoneda, Y. (2017). NMDA Receptor in Bone. In: Hashimoto, K. (eds) The NMDA Receptors. The Receptors, vol 30. Humana Press, Cham. https://doi.org/10.1007/978-3-319-49795-2_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-49795-2_8
Published:
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-49793-8
Online ISBN: 978-3-319-49795-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)